Skip to content

Clairfield advises Holland on the sale of Mauritskliniek to Corius

Holland Capital, a Dutch private equity firm, sold Mauritskliniek to Corius, a portfolio company of Swiss-based Ufenau Capital Partners.

Mauritskliniek is a specialised clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working and offer both insured and uninsured care.

CORIUS is a network of dermatology and phlebology practices. Doctors and partners of CORIUS deliver the highest level of quality and apply the most modern technology. CORIUS offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. CORIUS has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year.

Clairfield acted as the exclusive financial advisor to Holland Capital on the sale of Mauritskliniek to CORIUS.


Drapeau Germany Drapeau Netherlands Drapeau Switzerland

Advisor to the seller

Services :

Mergers & acquisitions

Sectors :


Countries involved :